Literature DB >> 15994292

Negative regulation of CXCR4-mediated chemotaxis by the lipid phosphatase activity of tumor suppressor PTEN.

Ping Gao1, Ronald L Wange, Ning Zhang, Joost J Oppenheim, O M Zack Howard.   

Abstract

Phosphatase and tensin homolog deleted on chromosome 10 (PTEN), a multifunctional tumor suppressor, has been shown to play a regulatory role in cell migration. Dictyostelium discoideum cells lacking PTEN exhibited impaired migration toward chemoattractant gradients. In the present study, we investigated the involvement of PTEN in chemotaxis of mammalian cells by examining PTEN-null Jurkat T cells. We observed that, in contrast to observations made in D discoideum, PTEN-null Jurkat T cells exhibited potent chemotactic responses to the chemokine stromal cell-derived factor 1alpha (SDF-1alpha), indicating that PTEN was not requisite for CXC chemokine receptor 4 (CXCR4)-mediated chemotaxis of Jurkat cells. Conversely, reconstitution of PTEN in Jurkat cells by using a tetracycline (Tet-on)-inducible expression system down-regulated CXCR4-mediated chemotaxis. Furthermore, we established the lipid phosphatase activity of PTEN as essential for its inhibitory effect on chemotaxis. In addition, using PTEN-expressing T-cell lines and primary T cells, we demonstrated that down-regulation of PTEN expression with vector-based small interfering RNAs (siRNAs) enhanced CXCR4-mediated chemotaxis. Based on these results, we conclude that PTEN expression negatively regulates chemotaxis of lymphoid mammalian cells via its lipid phosphatase activity. Our findings may account for the reported increase in metastatic activity of PTEN-null tumor cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994292      PMCID: PMC1895312          DOI: 10.1182/blood-2004-08-3362

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

Review 1.  Do phosphoinositide 3-kinases direct lymphocyte navigation?

Authors:  Stephen G Ward
Journal:  Trends Immunol       Date:  2004-02       Impact factor: 16.687

2.  Regulation of cell migration by the C2 domain of the tumor suppressor PTEN.

Authors:  Myrto Raftopoulou; Sandrine Etienne-Manneville; Annette Self; Sarah Nicholls; Alan Hall
Journal:  Science       Date:  2004-02-20       Impact factor: 47.728

3.  PTEN gene alterations in lymphoid neoplasms.

Authors:  A Sakai; C Thieblemont; A Wellmann; E S Jaffe; M Raffeld
Journal:  Blood       Date:  1998-11-01       Impact factor: 22.113

4.  Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN.

Authors:  M Tamura; J Gu; K Matsumoto; S Aota; R Parsons; K M Yamada
Journal:  Science       Date:  1998-06-05       Impact factor: 47.728

5.  Establishment of an IL-12-responsive T cell clone: its characterization and utilization in the quantitation of IL-12 activity.

Authors:  S Maruo; H J Ahn; W G Yu; M Tomura; M Wysocka; N Yamamoto; M Kobayashi; T Hamaoka; G Trinchieri; H Fuijiwara
Journal:  J Leukoc Biol       Date:  1997-03       Impact factor: 4.962

6.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

7.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Authors:  J Li; C Yen; D Liaw; K Podsypanina; S Bose; S I Wang; J Puc; C Miliaresis; L Rodgers; R McCombie; S H Bigner; B C Giovanella; M Ittmann; B Tycko; H Hibshoosh; M H Wigler; R Parsons
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

8.  Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma.

Authors:  U Schneider; H U Schwenk; G Bornkamm
Journal:  Int J Cancer       Date:  1977-05-15       Impact factor: 7.396

9.  The lipid phosphatase activity of PTEN is critical for its tumor supressor function.

Authors:  M P Myers; I Pass; I H Batty; J Van der Kaay; J P Stolarov; B A Hemmings; M H Wigler; C P Downes; N K Tonks
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

10.  Pten dose dictates cancer progression in the prostate.

Authors:  Lloyd C Trotman; Masaru Niki; Zohar A Dotan; Jason A Koutcher; Antonio Di Cristofano; Andrew Xiao; Alan S Khoo; Pradip Roy-Burman; Norman M Greenberg; Terry Van Dyke; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Journal:  PLoS Biol       Date:  2003-10-27       Impact factor: 8.029

View more
  13 in total

1.  PTEN negatively regulates engulfment of apoptotic cells by modulating activation of Rac GTPase.

Authors:  Subhanjan Mondal; Saurabh Ghosh-Roy; Fabien Loison; Yitang Li; Yonghui Jia; Chad Harris; David A Williams; Hongbo R Luo
Journal:  J Immunol       Date:  2011-10-31       Impact factor: 5.422

2.  Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells.

Authors:  Mahandranauth A Chetram; Valerie Odero-Marah; Cimona V Hinton
Journal:  Mol Cancer Res       Date:  2010-11-12       Impact factor: 5.852

3.  Tumor suppressor PTEN is a physiologic suppressor of chemoattractant-mediated neutrophil functions.

Authors:  Kulandayan K Subramanian; Yonghui Jia; Daocheng Zhu; Benjamin T Simms; Hakryul Jo; Hidenori Hattori; Jian You; Joseph P Mizgerd; Hongbo R Luo
Journal:  Blood       Date:  2007-01-03       Impact factor: 22.113

4.  Video-rate two-photon imaging of mouse footpad - a promising model for studying leukocyte recruitment dynamics during inflammation.

Authors:  B H Zinselmeyer; J N Lynch; X Zhang; T Aoshi; M J Miller
Journal:  Inflamm Res       Date:  2008-03       Impact factor: 4.575

Review 5.  Moving towards a paradigm: common mechanisms of chemotactic signaling in Dictyostelium and mammalian leukocytes.

Authors:  Yulia Artemenko; Thomas J Lampert; Peter N Devreotes
Journal:  Cell Mol Life Sci       Date:  2014-05-21       Impact factor: 9.261

Review 6.  Molecular control of PtdIns(3,4,5)P3 signaling in neutrophils.

Authors:  Hongbo R Luo; Subhanjan Mondal
Journal:  EMBO Rep       Date:  2015-01-09       Impact factor: 8.807

7.  Myeloid-specific deletion of tumor suppressor PTEN augments neutrophil transendothelial migration during inflammation.

Authors:  Bara Sarraj; Steffen Massberg; Yitang Li; Anongnard Kasorn; Kulandayan Subramanian; Fabien Loison; Leslie E Silberstein; Ulrich von Andrian; Hongbo R Luo
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

8.  Role of the tumor suppressor PTEN in antioxidant responsive element-mediated transcription and associated histone modifications.

Authors:  Kensuke Sakamoto; Kenta Iwasaki; Hiroyuki Sugiyama; Yoshiaki Tsuji
Journal:  Mol Biol Cell       Date:  2009-01-21       Impact factor: 4.138

Review 9.  A beta version of life: p110β takes center stage.

Authors:  Hashem A Dbouk; Jonathan M Backer
Journal:  Oncotarget       Date:  2010-12

Review 10.  Immunological considerations of modern animal models of malignant primary brain tumors.

Authors:  Michael E Sughrue; Isaac Yang; Ari J Kane; Martin J Rutkowski; Shanna Fang; C David James; Andrew T Parsa
Journal:  J Transl Med       Date:  2009-10-08       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.